Lymphocytes in barrier tissues play critical roles in host defense and homeostasis. These cells take up residence in tissues during defined developmental windows, when they may demonstrate distinct phenotypes and functions. Here, we utilized mass and flow cytometry to elucidate early features of human skin immunity. Although most conventional αβ T (Tconv) cells in fetal skin have a naive, proliferative phenotype, a subset of CD4+ Tconv and CD8+ cells demonstrate memory-like features and a propensity for interferon (IFN)γ production. Skin regulatory T cells dynamically accumulate over the second trimester in temporal and regional association with hair follicle development. These fetal skin regulatory T cells (Tregs) demonstrate an effector memory phenotype while differing from their adult counterparts in expression of key effector molecules. Thus, we identify features of prenatal skin lymphocytes that may have key implications for understanding antigen and allergen encounters in utero and in infancy.
Pubmed ID: 33294857 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD25 (IL-2 Receptor α)
View all literature mentionsThis monoclonal targets CD207
View all literature mentionsThis monoclonal targets CD24 (Heat Stable Antigen)
View all literature mentionsThis monoclonal targets CD8
View all literature mentionsThis monoclonal targets CD16
View all literature mentionsThis monoclonal targets CD1c
View all literature mentionsThis monoclonal targets CD45RO
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets TNF
View all literature mentionsThis monoclonal targets Human IL-22
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis unknown targets CD274/PDL1
View all literature mentionsThis monoclonal targets TCRgd
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD326
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD141 (BDCA-3)
View all literature mentionsThis unknown targets CD45
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets Nur77
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IL-17A
View all literature mentionsThis monoclonal targets CD1a
View all literature mentionsThis monoclonal targets Foxp3
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets HLA-DR
View all literature mentionsThis monoclonal targets CD127/IL-7Ra
View all literature mentionsThis monoclonal targets CD152/CTLA-4
View all literature mentionsThis monoclonal targets HLA-DR
View all literature mentionsThis monoclonal targets CD278 (ICOS)
View all literature mentionsThis monoclonal targets CD152 (CTLA-4)
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD56/NCAM
View all literature mentionsThis monoclonal targets IL-2
View all literature mentionsThis monoclonal targets CD45RO
View all literature mentionsThis monoclonal targets CD45RA
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD31 (PECAM-1)
View all literature mentions